Man Group plc

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1637460 LONDON, X0

Position in AXSM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$20,199,889

-$3,846,755 QoQ

Shares Held

82,526

-42.0% QoQ

Ownership

0.158%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#83

of 500 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Man Group plc holds $1,094,353,895 across 113 Biotechnology names. AXSM ranks #12 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	436,956	$272,459,544
2	INCY	Incyte Corp	952,941	$108,025,391
3	ONC	BeOne Medicines Ltd.	307,463	$87,617,731
4	VRTX	Vertex Pharmaceuticals Inc / Ma	139,233	$69,161,207
5	APGE	Apogee Therapeutics, Inc.	397,000	$52,693,809
6	ALNY	Alnylam Pharmaceuticals, Inc.	170,907	$51,448,133
7	JAZZ	Jazz Pharmaceuticals plc	152,877	$36,838,770
8	RVMD	Revolution Medicines, Inc.	173,439	$32,481,655

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,199,889	82,526	-42.0%	Shares	Defined	2026-08-14
2026-03-31	$24,046,644	142,271	-37.8%	Shares	Defined	2026-05-15
2025-12-31	$41,758,992	228,641	-20.6%	Shares	Defined	2026-02-17
2025-09-30	$34,966,426	287,908	-45.2%	Shares	Defined	2025-11-14
2025-06-30	$54,811,952	525,069	+2.3%	Shares	Defined	2025-08-14
2025-03-31	$59,856,965	513,221	+214.1%	Shares	Defined	2025-05-15
2024-12-31	$13,824,258	163,388	+40.3%	Shares	Defined	2025-02-14
2022-12-31	$8,985,027	116,492	+1357.2%	Shares	Defined	2023-02-14
2021-06-30	$539,275	7,994	-80.9%	Shares	Defined	2021-08-16
2021-03-31	$2,372,434	41,901	+3.4%	Shares	Defined	2021-05-17
2020-12-31	$3,300,023	40,506	-5.4%	Shares	Defined	2021-02-16
2020-09-30	$3,050,212	42,810	+196.7%	Shares	Defined	2020-11-16
2020-06-30	$1,187,053	14,427	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.